Close Menu

NEW YORK – Becton Dickinson on Tuesday said that preliminary fiscal first quarter 2021 revenues are expected to rise 26 percent year over year to $5.3 billion. On a currency-neutral basis, revenues are expected to increase 24 percent over the prior-year period.

The firm posted revenues of $4.2 billion in Q1 2020.

Analysts had estimated fiscal Q1 revenues of $4.69 billion.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.

CNN reports that two new studies suggest the B.1.1.7 SARS-CoV-2 variant may be more transmissible, but may not lead to more severe disease.

According to the Associated Press, a Swiss program aims to shepherd long-term science projects and diplomacy.

In PNAS this week: analysis of pathway affecting acute kidney injury, parental-specific allelic expression in horse placenta, and more.